XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Combined Condensed Statements of Earnings - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 25, 2020
Sep. 27, 2019
Sep. 25, 2020
Sep. 27, 2019
Sales:        
Sales $ 746.7 $ 714.4 $ 1,889.6 $ 2,028.8
Cost of sales:        
Cost of sales (415.4) (406.4) (1,064.2) (1,163.6)
Gross profit 331.3 308.0 825.4 865.2
Operating costs:        
Selling, general and administrative expenses (121.1) (118.3) (356.0) (362.9)
Research and development expenses (31.6) (34.8) (93.7) (102.0)
Impairment of goodwill 0.0 0.0 (85.3) 0.0
Operating profit 178.6 154.9 290.4 400.3
Non-operating income (expense):        
Interest (expense) income, net (0.2) 2.9 (0.8) 5.1
Other non-operating expenses (0.1) (0.2) (0.4) (0.6)
Earnings before income taxes 178.3 157.6 289.2 404.8
Income tax expense (37.3) (36.6) (84.0) (94.5)
Net earnings $ 141.0 $ 121.0 $ 205.2 $ 310.3
Net earnings per share:        
Basic and diluted (in dollars per share) $ 0.84 $ 0.72 $ 1.22 $ 1.84
Average common stock and common equivalent shares outstanding:        
Basic and diluted (in shares) 168.4 168.4 168.4 168.4
Products        
Sales:        
Sales $ 686.0 $ 639.7 $ 1,713.9 $ 1,813.0
Cost of sales:        
Cost of sales (367.0) (359.9) (926.0) (988.5)
Services        
Sales:        
Sales 60.7 74.7 175.7 215.8
Cost of sales:        
Cost of sales $ (48.4) $ (46.5) $ (138.2) $ (175.1)